価格表

在庫・価格 : 2025年04月26日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
ADAM9, Human, Recombinant, Carrier-free
データシート
939-AD-020 RSDアールアンドディー システムズ
R&D Systems, Inc.
20 μg 本製品は取扱中止になりました 追加

在庫・価格 : 2025年04月26日 08時45分 現在

ADAM9, Human, Recombinant, Carrier-free

  • 商品コード:939-AD-020
  • メーカー:RSD
  • 包装:20μg
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Hinkle CL et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 2004 Jun;279(23):24179-
Hinkle CL et al
2004/01/01
Application: Enzyme Activity, Sample Type: recombinant protein PubMed
2 Karadag A et al. ADAM-9 (MDC-9/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin. Blood 2006 Apr;107(8):
Karadag A et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Zhou BB et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006 Jul;10(1):39-50
Zhou BB et al
2006/01/01
Application: Enzyme Assay PubMed
4 Fridman JS et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007 Mar;13(6):1892-902
Fridman JS et al
2007/01/01
Application: Bioassay, Sample Type: Peptide Substrate PubMed
5 Moss ML et al. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 2007 Dec;282(49):35712-21
Moss ML et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: recombinant protein PubMed
6 Roychaudhuri R et al. ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury. J. Immunol. 2014 Sep;193(5):2469-82
Roychaudhuri R et al
2014/01/01
Application: Binding Assay, Sample Type: Whole Cells PubMed
7 Schlomann U et al. ADAM8 as a drug target in pancreatic cancer. Nat Commun 2015;6:6175
Schlomann U et al
2015/01/01
Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Hinkle CL et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 2004 Jun;279(23):24179-
    Hinkle CL et al
    2004/01/01
  • 備考:
    Application: Enzyme Activity, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Karadag A et al. ADAM-9 (MDC-9/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin. Blood 2006 Apr;107(8):
    Karadag A et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Zhou BB et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006 Jul;10(1):39-50
    Zhou BB et al
    2006/01/01
  • 備考:
    Application: Enzyme Assay
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fridman JS et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007 Mar;13(6):1892-902
    Fridman JS et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Peptide Substrate
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Moss ML et al. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J. Biol. Chem. 2007 Dec;282(49):35712-21
    Moss ML et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: recombinant protein
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Roychaudhuri R et al. ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury. J. Immunol. 2014 Sep;193(5):2469-82
    Roychaudhuri R et al
    2014/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Schlomann U et al. ADAM8 as a drug target in pancreatic cancer. Nat Commun 2015;6:6175
    Schlomann U et al
    2015/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed